Machine Learning Improves Childhood Asthma Risk

Medically reviewed | Published: | Evidence level: 1A
A machine-learning tool analyzing information already available in children's electronic health records helped pediatricians assess asthma risk more accurately in standardized clinical scenarios. The findings support further study of artificial intelligence as a clinical decision aid, but real-world validation is needed before such tools can guide routine care.
📅 Published:
Reviewed by iMedic Medical Editorial Team
📄 Pediatric Health

Quick Facts

Data Source
Existing electronic health records
Test Format
Standardized clinical scenarios
Clinical Role
Decision support, not diagnosis

How Can Machine Learning Identify Childhood Asthma Risk?

Quick answer: Machine learning can detect combinations of clinical details in electronic health records that may indicate an elevated risk of asthma.

Diagnosing asthma in children can be difficult because wheezing, coughing and shortness of breath may also occur with respiratory infections or other conditions. Younger children may be unable to complete lung-function testing reliably, while symptoms can vary substantially between appointments. A machine-learning system may help by examining patterns across information already documented in the electronic health record rather than relying on a single symptom or test.

The reported tool improved pediatricians' assessment of asthma risk when they evaluated standardized clinical case scenarios. This suggests that computational support may help clinicians recognize patterns that are easy to overlook when records contain numerous diagnoses, prescriptions and prior encounters. The result does not establish that the system can diagnose asthma independently or improve patient outcomes in everyday practice.

Could Artificial Intelligence Lead to Earlier Asthma Care?

Quick answer: Earlier recognition could prompt a more focused clinical assessment, but an algorithm should not replace examination, testing or medical judgment.

When a child is flagged as potentially being at higher risk, a clinician could review the symptom history, possible triggers, family history and response to previous treatment more closely. Depending on the child's age, evaluation may also include spirometry with bronchodilator testing. The Global Initiative for Asthma emphasizes confirming the diagnosis whenever possible because both missed asthma and incorrect labeling can expose children to avoidable harm.

Earlier recognition may help families receive education about inhaler technique, trigger reduction and appropriate follow-up. However, a risk prediction is not the same as a confirmed diagnosis. Pediatricians must still consider alternative explanations for recurring respiratory symptoms and assess whether urgent treatment or referral is needed.

What Evidence Is Needed Before the Tool Is Used Routinely?

Quick answer: The system needs prospective testing in diverse clinical settings to show that it is accurate, equitable and beneficial for children.

Performance in standardized scenarios is an important early test, but it cannot reproduce the complexity of real pediatric care. Future studies should evaluate the tool across different hospitals, record systems, age groups and patient populations. Researchers should also determine whether its recommendations change clinical decisions appropriately and lead to earlier accurate diagnosis without causing excessive testing or treatment.

Electronic health records can contain missing, inconsistent or historically biased information, which may affect an algorithm's predictions. Safe implementation therefore requires transparent validation, monitoring for unequal performance and a clear way for clinicians to question or override a recommendation. Families should also be told when automated analysis materially contributes to a child's assessment.

Frequently Asked Questions

No. A risk tool can support clinical assessment, but asthma diagnosis still requires a clinician to evaluate symptoms, medical history, examination findings and age-appropriate testing.

Recurring wheezing, nighttime coughing, breathing difficulty, reduced activity or symptoms triggered by exercise, allergens or respiratory infections should be discussed with a pediatric clinician.

Not necessarily. The reported improvement was demonstrated in standardized clinical scenarios, so prospective real-world studies and local validation are still needed.

References

  1. Medical Xpress. “Machine learning improves identification of asthma risk in children.” July 2026.
  2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2025.
  3. Cloutier MM, Baptist AP, Blake KV, et al. 2020 Focused Updates to the Asthma Management Guidelines. Journal of Allergy and Clinical Immunology. 2020;146(6):1217-1270.